Moderna, Inc.
About Moderna, Inc.
Moderna, Inc. is a biotechnology company founded in 2010 and headquartered in Cambridge, Massachusetts. It develops messenger RNA medicines and formed partnerships with Merck for cancer treatments and Vertex Pharmaceuticals for cystic fibrosis treatments. In 2016, the Bill & Melinda Gates Foundation provided at least $20 million in grant funding. The company went public in December 2018 via the largest biotechnology IPO in history, raising $621 million.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Completed $8.37M Rule 144 placement on NASDAQ
- 2018 IPO raised $621M as largest biotech offering
- Partnerships include Merck for cancer and Vertex for cystic fibrosis
- Received $20M grant from Bill & Melinda Gates Foundation in 2016
Ask StreetZero about Moderna, Inc.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account